Join Sterne Kessler’s Christopher Gallo, Ph.D., and Pratibha Khanduri, Ph.D., as they explore the battleground surrounding follow-on biopharmaceutical patents, including strategies for obtaining these patents and defending and challenging these patents before the PTAB and in district court litigation.

While these patents face criticism as “patent thickets” that delay low-cost competitors, the underlying follow-on research regularly delivers significant public health benefits, including optimized drug delivery systems, repurposed life-saving indications, and improved dosing regimens.

Successfully navigating this complex landscape requires patent owners and challengers alike to understand competing operational strategies, emerging trends, and the rapidly evolving judicial environment.

Continuing Legal Education Credits

General CLE credit is pending for VA, CA, TX, NY, and IL.

Related Professionals

Related Industries

Related Services